GALWAY, IRELAND--December 1, 2016--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharmaceutical major Pfizer (NYSE:PFE) (New York, New York) has axed a planned 400 million euro ($426 million) expansion at its Irish manufacturing operations in Dublin. Within this article: Details axed projects following drug trial failure
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!